Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses

Clinical development directions in oncolytic viral therapy

(2011) R M Eager et al.   CANCER GENE THERAPY

The emerging role of viruses in the treatment of solid tumours

(2011) M.G. Bourke et al.   CANCER TREATMENT REVIEWS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Four faces of cellular senescence

(2011) Francis Rodier et al.   JOURNAL OF CELL BIOLOGY

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

(2011) Tae-Won Kang et al.   NATURE

Cellular senescence predicts treatment outcome in metastasised colorectal cancer

(2010) A M Haugstetter et al.   BRITISH JOURNAL OF CANCER

Exploiting cellular senescence to treat cancer and circumvent drug resistance

(2010) Qin Yan et al.   CANCER BIOLOGY & THERAPY

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

(2010) E. Galanis et al.   CANCER RESEARCH

Therapeutic Potential of Oncolytic Measles Virus: Promises and Challenges

(2010) E Galanis   CLINICAL PHARMACOLOGY & THERAPEUTICS

Quantitative assessment of markers for cell senescence

(2010) Conor Lawless et al.   EXPERIMENTAL GERONTOLOGY

Therapy-Induced Senescence in Cancer

(2010) Jonathan A. Ewald et al.   JNCI-Journal of the National Cancer Institute

Induction of Reactive Oxygen Species by Human T-Cell Leukemia Virus Type 1 Tax Correlates with DNA Damage and Expression of Cellular Senescence Marker

(2010) T. Kinjo et al.   JOURNAL OF VIROLOGY

A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers

(2010) Jean-Simon Diallo et al.   MOLECULAR THERAPY

Senescence: an antiviral defense that is tumor suppressive?

(2009) R. R. Reddel   CARCINOGENESIS

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

(2008) Roberto Cattaneo et al.   NATURE REVIEWS MICROBIOLOGY